Bone loss induced by cancer treatment and its management

被引：25

作者：

Delmas, PD ^{[1
]}

Fontana, A ^{[1
]}

机构：

[1] Hop Edouard Herriot, INSERM, Res Unit 403, F-69437 Lyon 03, France

来源：

EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷 / 02期

关键词：

D O I：

10.1016/S0959-8049(97)10135-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：260 / 262

页数：3

共 21 条

[1] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].

Berenson, JR ;

Lichtenstein, A ;

Porter, L ;

Dimopoulos, MA ;

Bordoni, R ;

George, S ;

Lipton, A ;

Keller, A ;

Ballester, O ;

Kovacs, MJ ;

Blacklock, HA ;

Bell, R ;

Simeone, J ;

Reitsma, DJ ;

Heffernan, M ;

Seaman, J ;

Knight, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493

[2] RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS [J].

BLACK, LJ ;

SATO, M ;

ROWLEY, ER ;

MAGEE, DE ;

BEKELE, A ;

WILLIAMS, DC ;

CULLINAN, GJ ;

BENDELE, R ;

KAUFFMAN, RF ;

BENSCH, WR ;

FROLIK, CA ;

TERMINE, JD ;

BRYANT, HU .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :63-69

[3] BONE-MINERAL DENSITY AFTER ADJUVANT CHEMOTHERAPY FOR PREMENOPAUSAL BREAST-CANCER [J].

BRUNING, PF ;

PIT, MJ ;

DEJONGBAKKER, M ;

VANDENENDE, A ;

HART, A ;

VANENK, A .

BRITISH JOURNAL OF CANCER, 1990, 61 (02) :308-310

[4]

CHAPMAN RM, 1981, BLOOD, V58, P849

[5]

COOMBES RC, 1995, CANCER RES, V55, P1070

[6] Osteoporosis after orchiectomy for prostate cancer [J].

Daniell, HW .

JOURNAL OF UROLOGY, 1997, 157 (02) :439-444

[7]

Delmas P D, 1997, Osteoporos Int, V7 Suppl 1, pS3

[8] Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women [J].

Delmas, PD ;

Bjarnason, NH ;

Mitlak, BH ;

Ravoux, AC ;

Shah, AS ;

Huster, WJ ;

Draper, M ;

Christiansen, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (23) :1641-1647

[9] Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: A double-blind, placebo-controlled study [J].

Delmas, PD ;

Balena, R ;

Confravreux, E ;

Hardouin, C ;

Hardy, P ;

Bremond, A .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :955-962

[10] A THERAPEUTIC DILEMMA - SUPPRESSIVE DOSES OF THYROXINE SIGNIFICANTLY REDUCE BONE-MINERAL MEASUREMENTS IN BOTH PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN WITH THYROID-CARCINOMA [J].

DIAMOND, T ;

NERY, L ;

HALES, I .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06) :1184-1188

← 1 2 3 →